These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 16953381

  • 1. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
    Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T.
    Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
    [Abstract] [Full Text] [Related]

  • 2. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, McQuade RD.
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.
    Tran-Johnson TK, Sack DA, Marcus RN, Auby P, McQuade RD, Oren DA.
    J Clin Psychiatry; 2007 Jan; 68(1):111-9. PubMed ID: 17284138
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
    [Abstract] [Full Text] [Related]

  • 5. Intramuscular aripiprazole in the control of agitation.
    Currier GW, Citrome LL, Zimbroff DL, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [Abstract] [Full Text] [Related]

  • 6. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Zimbroff DL, Marcus RN, Manos G, Stock E, McQuade RD, Auby P, Oren DA.
    J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
    [Abstract] [Full Text] [Related]

  • 7. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
    Mendelowitz AJ.
    Ann Clin Psychiatry; 2004 Apr; 16(3):145-54. PubMed ID: 15517847
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW.
    J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
    [Abstract] [Full Text] [Related]

  • 9. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL, Hwang TJ, Chen YH, Huang GH, Hsieh MH, Chen HH, Hwu HG.
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.
    Kane JM, Barnes TR, Correll CU, Sachs G, Buckley P, Eudicone J, McQuade R, Tran QV, Pikalov A, Assunção-Talbott S.
    J Psychopharmacol; 2010 Jul; 24(7):1019-29. PubMed ID: 20008446
    [Abstract] [Full Text] [Related]

  • 11. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T, Perry CM.
    Drugs; 2004 Jul; 64(15):1715-36. PubMed ID: 15257633
    [Abstract] [Full Text] [Related]

  • 12. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S.
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [Abstract] [Full Text] [Related]

  • 13. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
    Janicak PG, Glick ID, Marder SR, Crandall DT, McQuade RD, Marcus RN, Eudicone JM, Assunção-Talbott S.
    J Clin Psychiatry; 2009 Jan; 70(1):25-35. PubMed ID: 19192472
    [Abstract] [Full Text] [Related]

  • 14. Intramuscular aripiprazole in the acute management of psychomotor agitation.
    De Filippis S, Cuomo I, Lionetto L, Janiri D, Simmaco M, Caloro M, De Persis S, Piazzi G, Simonetti A, Telesforo CL, Sciarretta A, Caccia F, Gentile G, Kotzalidis GD, Girardi P.
    Pharmacotherapy; 2013 Jun; 33(6):603-14. PubMed ID: 23505124
    [Abstract] [Full Text] [Related]

  • 15. Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial.
    Kittipeerachon M, Chaichan W.
    Schizophr Res; 2016 Oct; 176(2-3):231-238. PubMed ID: 27461399
    [Abstract] [Full Text] [Related]

  • 16. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.
    Kane JM, Sanchez R, Perry PP, Jin N, Johnson BR, Forbes RA, McQuade RD, Carson WH, Fleischhacker WW.
    J Clin Psychiatry; 2012 May; 73(5):617-24. PubMed ID: 22697189
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P.
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ, Stauffer VL, Kollack-Walker S, Chen L, Sniadecki J.
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [Abstract] [Full Text] [Related]

  • 19. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
    Brook S, Walden J, Benattia I, Siu CO, Romano SJ.
    Psychopharmacology (Berl); 2005 Apr; 178(4):514-23. PubMed ID: 15650846
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.
    Chan HY, Ree SC, Su LW, Chen JJ, Chou SY, Chen CK, Chen YS.
    J Clin Psychopharmacol; 2014 Jun; 34(3):355-8. PubMed ID: 24743717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.